FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹19 Cr | ₹21 Cr | ₹45 Cr | ₹32 Cr | ₹14 Cr |
What is the latest Total Non-Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹19 Cr |
Mar2023 | ₹21 Cr |
Mar2022 | ₹45 Cr |
Mar2021 | ₹32 Cr |
Mar2020 | ₹14 Cr |
How is Total Non-Current Liabilities of FREDUN PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹19 Cr | -9.16 | |
Mar2023 | ₹21 Cr | -52.97 | |
Mar2022 | ₹45 Cr | 40.78 | |
Mar2021 | ₹32 Cr | 128.14 | |
Mar2020 | ₹14 Cr | - |
Compare Total Non-Current Liabilities of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹379.5 Cr | -1.8% | 12.2% | -6.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | -1.8% |
12.2% |
-6.5% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses